Document and Entity Information | Mar. 28, 2023 |
Document And Entity Information [Line Items] | |
Document Type | 8-K |
Document Period End Date | Mar. 28, 2023 |
Entity Registrant Name | Sensei Biotherapeutics, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-39980 |
Entity Tax Identification Number | 83-1863385 |
Entity Address, Address Line One | 1405 Research Blvd |
Entity Address, Address Line Two | Suite 125 |
Entity Address, City or Town | Rockville |
Entity Address, State or Province | MD |
Entity Address, Postal Zip Code | 20850 |
City Area Code | 240 |
Local Phone Number | 243-8000 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Amendment Flag | false |
Entity Central Index Key | 0001829802 |
Former Address [Member] | |
Document And Entity Information [Line Items] | |
Entity Address, Address Line One | 451 D Street |
Entity Address, Address Line Two | Suite 710 |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02210 |
Common Stock [Member] | |
Document And Entity Information [Line Items] | |
Title of 12(b) Security | Common Stock |
Trading Symbol | SNSE |
Security Exchange Name | NASDAQ |
Series A Preferred Stock Purchase Rights [Member] | |
Document And Entity Information [Line Items] | |
Title of 12(b) Security | Series A Preferred Stock Purchase Rights |
Security Exchange Name | NASDAQ |
No Trading Symbol Flag | true |